BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » Stem Cells » Page 168

3 Eerie Similarities between the Acquisition of Cord Blood Registry® (CBR) and ViaCord

July 9, 2015 By Cade Hildreth (CEO) Leave a Comment

CBR® ACQUIRED BY AMAG PHARMA FOR SAME MULTIPLE ON REVENUE AS PERKINELMER PAID FOR VIACORD

Cord Blood Registry® (CBR) recently made headlines by announcing that it had entered into a definitive agreement to be acquired by AMAG Pharmaceuticals for $700M. While the announcement was new, there were aspects of the deal that seemed eerily familiar.
[Read more…]

Filed Under: Cord Blood, HSCs Tagged With: AMAG Pharmaceuticals, cord blood, Cord Blood Registry, PerkinElmer, viacord

Dental Pulp Stem Cell News Round-Up | 3rd Quarter 2015

July 8, 2015 By Cade Hildreth (CEO) Leave a Comment

DENTAL PULP STEM CELLS NEWS ROUND-UP | 2ND QUARTER 2015

The dental pulp stem cell industry is a rapidly evolving industry. Every month there are major events occurring in the sector that shift industry dynamics. Often, these events are announcements of technical or scientific advancements.  Sometimes they are announcements of major industry alliances. Occasionally, they are announcements of a new industry competitor, a major milestone, or a significant funding award.

For those of us interested in the dental pulp stem cell industry, tracking these shifting industry dynamics is of paramount importance.  For this reason, this post covers the most significant neural stem cell industry news events as of July 2015.

[Read more…]

Filed Under: Stem Cells Tagged With: dental pulp stem cell, dental pulp stem cell transplants, industry news, market research, stem cell research, Tooth Bank

5 Types of Cord Blood Market Participants Impacted by AMAG Pharma’s Acquisition of Cord Blood Registry (CBR®)

June 30, 2015 By Cade Hildreth (CEO) Leave a Comment

Cord Blood Registry Acquired by AMAG Pharmaceuticals

On June 29, 2015, AMAG Pharmaceuticals released news that reverberated throughout the cord blood banking industry worldwide, announcing that it had entered into a definitive agreement to acquire Cord Blood Registry (CBR®) for $700 million. The acquisition is expected to close during the third-quarter of 2015, based on regulatory approvals and execution of agreed upon terms and conditions.

Direct Participants in the Cord Blood Deal

Founded in 1992 and headquartered in San Bruno, California, Cord Blood Registry® is the largest cord blood bank in the United States and the world.  CBR® currently stores over 500,000 preserved cord blood and cord tissue units, which is substantially more than its nearest competitor, ViaCord, which has approximately 350,000 units stored.   [Read more…]

Filed Under: Cord Blood, HSCs, Stem Cells Tagged With: acquisition, AMAG Pharmaceuticals, cord blood, Cord Blood Registry

[ALLIANCE] Sistemic and RoosterBio Developing Regenerative Technologies Involving miRNA and Mesenchymal Stem/Stromal Cells

June 26, 2015 By Cade Hildreth (CEO) Leave a Comment

Sistemic and RoosterBio Developing Regenerative Technologies Involving miRNA and Mesenchymal Stem/Stromal Cells

Short Summary:  RoosterBio, Inc. and Sistemic have entered into an agreement to synergistically develop microRNA (miRNA)-based cell characterization technologies that will create more precise and relevant characterization panels for human mesenchymal stem cell (hMSC) products and in process cell banks.
[Read more…]

Filed Under: MSCs, Stem Cells Tagged With: hMSC, hMSC regenerative technology, human mesenchymal stem cell, microRNA, miRNA, RoosterBio, Sistemic

“Blockbuster” Year for Induced Pluripotent Stem Cells Provides Expanding Opportunities, with Japan at the Forefront of Global Innovation

June 26, 2015 By Cade Hildreth (CEO) Leave a Comment

"Blockbuster" Year for Induced Pluripotent Stem Cells Provides Expanding Opportunities, with Japan at the Forefront of Global Innovation

To create profitable products and services, stem cell industry executives need to stay informed about rapidly-evolving industry trends. For this reason, this post explores important trends, events, and metrics of importance within the induced pluripotent stem cell (iPSC) industry. It also considers geographical dominance within the industry.
[Read more…]

Filed Under: iPS Cells, Stem Cells Tagged With: induced pluripotent stem cells, industry trends, iPS cells, iPSC clinical applications, iPSC development, iPSC industry, iPSCs, Japan, stem cell research, United States

  • « Previous Page
  • 1
  • …
  • 166
  • 167
  • 168
  • 169
  • 170
  • …
  • 178
  • Next Page »

Nanocellect

Marathon Products

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram
Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Top Rated Products

  • Job Posting on BioInformant Job Posting on BioInformant.com - Your Perfect Hire Is In Our Audience
    Rated 0 out of 5
    $297
  • U.S. Cord Blood Banking Survey Cord Blood Banking Survey of U.S. Parents [2017]
    Rated 0 out of 5
    $197
  • Exosome Companies 2020 Global Database of Exosome Companies
    Rated 0 out of 5
    $149 $97

Featured Posts

Cord Blood Market Segmentation

Cord Blood Market Segmentation – Biobanking, HSCT, Cellular Therapy, Genetic Manipulation, & Research Tools

CAR-T Companies

CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide

Who discovered stem cells?

Who Discovered Stem Cells? The Answers Revealed

My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: Info@BioInformant.com | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.